WALL STREET REVIEW 26.2.19
Summary of the day (the day was) by HAIM BARAN
A mixed trend with a tendency to fall ...
.... 0.07% -0.13% - ....
The day after... The market began to decline by 0.2-5% ... Continue the negative momentum after the attempt to attack the resistance level 2800-20. And soon the market also recovered... It turns out that there is no pressure to sell .. And the indices as the day progressed moved to positive territory up to + 0.2%. In the last half hour, the sellers returned and lowered the indices to the red side.
S & P dropped 0.08% to 2794. Trading in a very tight range today 2790-2803 ... Subsidies 2780, 2760, 2740 Resistance 2800-20, 2860 ...
The DOW fell 0.13% to 26058 supported at the 26000 level and received a roof at 26150 today. Support 26000, 25500, 25100. Resistance 26250-300 and peak ...
The NASDAQ fell 0.07% to 7549 daily support 7535 resistance 7570 .. Support 7465-500, 7400, 7200 resistance 7570, 7670, 7750 ...
The market tried to come down today and came to buyers who tried to rise and reached the sellers in a place lower than yesterday ... They seem to be more determined at the moment (red candles close relative oils)... The realization seems to peep out ....... but he is a bit shy
Especially after two green months, the Russell 2000 made a reversal of the average 200 (usually a right-hand pointer). So caution is required on the one hand ... and on the other hand, the big stocks have returned to work.
DDS rose 19.8%, SERV rose 16.5%, ESTY rose 16.3%, AERI rose 14.8%, THC rose 11.2%, TFCH rose 10.8%, MNK rose 10.2%, and non-stop MRNA rose another 9.5% % (Already been + 18%) on a huge turnover of 105 million shares, WP rose 8.2%, IMMU rose 7%, CRON resumes rising and rose 6.9% .....
We note the TNDM that rises 14% (00:05) in After after reports that surprised everyone for the better
Declined: CDEV stock fell 22.6%, MEDP fell 22%, RLGY fell 20.7%, MDB declined 8.9%, ETRN dropped 7.6% .....
Good night
.
.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.